Developharma, an affiliate of Rivopharm, is a research & Development Company focused in the field of generic pharmaceutical products and provides development services to Rivopharm, as well as to third party pharmaceutical companies, either on an exclusive basis or as possible joint-development projects.

Formulation development activities include:
• Pre-formulation studies
• Stability studies
• Formulation development
• Batch scale-up and technology transfer
• Analytical method development
• Product registration support
• Manufacture of clinical trial batches

All activities are carried out in compliance with Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP) and the company has been successfully inspected and approved by both the Swiss Authorities and by the US-FDA. Developharma’s pilot plant was conceived as a small factory to cover all aspects of oral solid dosage forms with full scale-up commercial manufacturing capability to provide an efficient product development platform. Continuous investments are made at both the formulation and analytical levels to further expand the research and development activities
with new technologies.